About PHA Staff

This author has not yet filled in any details.
So far PHA Staff has created 353 blog entries.

Hope Is Focus of Pulmonary Hypertension Awareness Month

2019-10-17T19:15:19+00:00October 17th, 2019|

November is Pulmonary Hypertension Awareness Month, and anticipation is growing at the Pulmonary Hypertension Association (PHA). Starting Nov. 1, PHA will launch a month-long awareness campaign called “PHaces of Hope,” which will focus on the faces of those who bravely fight pulmonary hypertension (PH), showing how PH can affect individuals of any age, everywhere.

A Conversation with Pulmonary Hypertension Expert Dr. Jeffery Sager

2019-10-17T19:13:02+00:00October 17th, 2019|

Dr. Jeffrey Sager is the director of the Pulmonary Hypertension Care Center (PHCC) at Cottage Rehabilitation Hospital & Goleta Valley Cottage Hospital in Santa Barbara, Calif. He also serves on the Pulmonary Hypertension Association’s (PHA’s) Scientific Leadership Council. In this story, he discusses his work with pulmonary hypertension (PH) and his connection to PHA.

Resources for Navigating Medicare Open Enrollment

2019-10-17T19:11:37+00:00October 17th, 2019|

Medicare Open Enrollment has begun. Now through Dec. 7, 2019, individuals with health insurance through Medicare can make changes to their existing coverage. The Pulmonary Hypertension Association (PHA) offers guidelines for choosing Medicare coverage at https://PHAssociation.org/Patients/Insurance/Medicare/. On this page you will find helpful videos, and other resources to help with you better understand Medicare. One-on-one

PH Patient Shares Her Story and Hopes for the Future

2019-10-17T19:28:21+00:00October 17th, 2019|

The Pulmonary Hypertension Association’s (PHA’s) The Right Heart blog brings you a story about a patient that was diagnosed with pulmonary hypertension (PH) in October 2015 after realizing she had a family history of this disease. CraShundra Richardson started experiencing fatigue early on and went to her doctor. Her doctor recommended that she get

New PAH Treatment System Submitted for FDA Approval

2019-10-07T17:43:07+00:00October 3rd, 2019|

Trevyent®, a new treatment system that utilizes subcutaneous delivery of treprostinil for pulmonary arterial hypertension (PAH) patients, was submitted to the U.S. Food & Drug Administration (FDA) for approval. The FDA received a New Drug Application (NDA) by United Therapeutics Corporation in September for Trevyent, a disposable pump and skin patch system or PatchPump®

Volunteer Spotlight: Treating the Condition and Beyond

2019-10-03T18:27:53+00:00October 3rd, 2019|

Kristine Ritenour, a pulmonary hypertension (PH) nurse coordinator at the Medical University of South Carolina, serves as the Pulmonary Hypertension Association (PHA) support group leader of the Lowcountry Charleston Support Group in Charleston, S.C. Kristine started leading a support group because she believes it’s important to give patients a place to connect and learn more